Results 151 to 160 of about 6,202 (185)

Biomechanical platelet activation: diseases that require a new class of antiplatelet therapeutics. [PDF]

Am J Physiol Cell Physiol
Gupta R, Alkhalfan F, Wheeler J, Cameron SJ.   +3 more
europepmc   +1 more source

Platelet-bioengineered hiPSC-sEVs achieve targeted repair of fibrotic sinoatrial node in preclinical SND models. [PDF]

Nat Commun
Liu H, Zeng Y, Fan W, Lan X, Liu C, He Y, Li Z, Jia K, Wan J, Liao B.   +9 more
europepmc   +1 more source

The Role of HSP47 in Thrombotic Disorders: Molecular Mechanism and Therapeutic Potential. [PDF]

Curr Issues Mol Biol
Teodoru M, Stoia OM, Vladoiu MG, Tonch-Cerbu AK.   +3 more
europepmc   +1 more source

Untersuchungen zur Funktion und Regulation von CD84, GPVI und Orai2 in genetisch veränderten Mäusen

, 2013
Hofmann, Sebastian
openalex   +1 more source

Platelets and diseases: signal transduction and advances in targeted therapy. [PDF]

Signal Transduct Target Ther
Tian Y, Zong Y, Pang Y, Zheng Z, Ma Y, Zhang C, Gao J.   +6 more
europepmc   +1 more source

Qiliqiangxin capsule attenuates platelet activation and thrombosis by suppressing Ca²⁺ influx and PKC signaling. [PDF]

Thromb J
Han L, Zhang W, Huo C, Zhou A, Huang Z, Wang Y, Yang B, Cao L, Zhang S, Zheng J, Xia R.   +10 more
europepmc   +1 more source

TRIPLE Score: GPVI and CD36 Expression Predict a Prothrombotic Platelet Function Phenotype. [PDF]

Circ Res
Bye AP, Kriek N, Kempster C, Dunster JL, Mitchell JL, Sage T, Rawlings S, Diaz Alonso MV, Shpakova V, Whyte A, Dymott L, Mark S, Brunton M, Batista J, McKinney H, Thomas P, Downes K, Unsworth AJ, Ruparelia N, McKenna C, Jones CI, Gibbins JM.   +21 more
europepmc   +1 more source

Non-genomic effects of the Pregnane X Receptor negatively regulate GPVI-mediated platelet signalling [PDF]

, 2019
Gagan D. Flora, Sahli, Khalid, Parvathy Sasikumar, Lisa‐Marie Holbrook, Alexander R. Stainer, Marilena Crescente, Sarah Khaled AlOuda, Tanya Sage, Amanda J. Unsworth, Jonathan M. Gibbins   +9 more
openalex  

Platelet dysfunction in Ehlers–Danlos syndrome is associated with low GPVI and PAR1 expression on platelets [PDF]

Mariia Kumskova, Gagan D. Flora, Manasa K. Nayak, Ivan Budnik, Tarun Barbhuyan, Madankumar Ghatge, Aditi Jain, Abhishek Jha, Rakeshkumar Patel, Neelam Chauhan, Anjali Sharathkumar, Janice M. Staber, Steven R. Lentz, Anil K. Chauhan   +13 more
openalex   +1 more source

Plasma chemokines indicate enhanced bleeding in patients with chronic coronary syndrome undergoing percutaneous coronary stenting. [PDF]

Clin Res Cardiol
Harm T, Lahu S, Mayer K, Rath D, Geisler T, Müller KAL, Janisch M, Adler K, Münch G, Massberg S, Kastrati A, Gawaz MP.   +11 more
europepmc   +1 more source